Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $145.67 -0.66%
EPS Growth %: -14.2%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -14.2%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- Needham on Barnes & Noble Education (BNED): 'we remain buyers on the weakness'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
